
MDGEF
Healthcare · Biotechnology · $38.2M market cap
Latest report
After the close
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2024
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 17, 2023 | After the close | — | -0.17 | — |
| Apr 5, 2021 | Before the open | 0.00 | -0.12 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | -0.14 | — |
| Nov 12, 2020 | Before the open | 0.00 | -0.41 | — |
| Aug 7, 2020 | Before the open | — | -0.39 | — |
| May 14, 2020 | After the close | 0.00 | -0.27 | — |
| Mar 27, 2020 | After the close | — | -0.28 | — |
| Nov 13, 2019 | Before the open | — | 0.00 | — |
| Aug 7, 2019 | Before the open | — | -0.25 | — |
| May 14, 2019 | Before the open | — | -0.23 | — |
| Mar 27, 2019 | Before the open | — | -0.26 | — |
| Nov 13, 2018 | Before the open | — | -0.38 | — |
| Aug 7, 2018 | Before the open | — | -0.25 | — |
| May 9, 2018 |
Medigene AG is in the process of liquidation of its remaining assets. Previously, the company was engaged in the development of T-cell therapies for the treatment of cancer. Medigene AG was founded in 1994 and is headquartered in Munich, Germany.
| Before the open |
| — |
| -0.19 |
| — |
| Mar 27, 2018 | After the close | — | -0.23 | — |